His main research concerns Tuberculosis, Internal medicine, Surgery, Mycobacterium tuberculosis and Extensively drug-resistant tuberculosis. The Tuberculosis study combines topics in areas such as Immunology, Public health and Intensive care medicine. His Intensive care medicine research incorporates themes from Disease, MEDLINE and Risk factor.
The Internal medicine study which covers Multiple drug resistance that intersects with Scientific evidence and Drug. His Surgery study incorporates themes from Adverse effect and Drug resistance. Giovanni Sotgiu has included themes like Regimen, Multi-drug-resistant tuberculosis, Ethionamide and Capreomycin in his Extensively drug-resistant tuberculosis study.
His primary scientific interests are in Tuberculosis, Internal medicine, Intensive care medicine, Surgery and Immunology. Giovanni Sotgiu studies Tuberculosis, namely Mycobacterium tuberculosis. His research is interdisciplinary, bridging the disciplines of Gastroenterology and Internal medicine.
His research brings together the fields of MEDLINE and Intensive care medicine. His Surgery study combines topics in areas such as Extensively drug-resistant tuberculosis and Drug resistance. His studies deal with areas such as Epidemiology and Pediatrics as well as Incidence.
Giovanni Sotgiu focuses on Internal medicine, Tuberculosis, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2 and 2019-20 coronavirus outbreak. His research links Gastroenterology with Internal medicine. The study incorporates disciplines such as Cohort study, Environmental health, Intensive care medicine, Disease and Public health in addition to Tuberculosis.
His research in Cohort study intersects with topics in Observational study and Pediatrics. In Coronavirus disease 2019, Giovanni Sotgiu works on issues like Pneumonia, which are connected to Intensive care unit. His work in Retrospective cohort study covers topics such as Incidence which are related to areas like Epidemiology.
Giovanni Sotgiu spends much of his time researching Coronavirus disease 2019, Tuberculosis, Pandemic, 2019-20 coronavirus outbreak and Internal medicine. His Tuberculosis study integrates concerns from other disciplines, such as Cohort study, Contact tracing, Intensive care medicine, Disease and Coinfection. His study looks at the intersection of Disease and topics like Public health with Epidemiology, Urbanization and Local government.
His Pandemic research is multidisciplinary, relying on both Outbreak, Social stigma, Betacoronavirus and Environmental health. Giovanni Sotgiu focuses mostly in the field of 2019-20 coronavirus outbreak, narrowing it down to topics relating to Severe acute respiratory syndrome coronavirus 2 and, in certain cases, MEDLINE. His work on Etiology, Air trapping and Quality of life as part of general Internal medicine research is often related to Vital capacity and DLCO, thus linking different fields of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Payam Nahid;Susan E. Dorman;Narges Alipanah;Pennan M. Barry.
Clinical Infectious Diseases (2016)
Towards tuberculosis elimination: an action framework for low-incidence countries
Knut Lönnroth;Giovanni Battista Migliori;Ibrahim Abubakar;Lia D'Ambrosio.
European Respiratory Journal (2015)
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
José A Caminero;Giovanni Sotgiu;Alimuddin Zumla;Giovanni Battista Migliori.
Lancet Infectious Diseases (2010)
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis
Martina Sester;Giovanni Sotgiu;Christoph Lange;Claudia Giehl.
European Respiratory Journal (2011)
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja;David Ashkin;Monika Avendano;Rita Banerjee.
PLOS Medicine (2012)
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
Haileyesus Getahun;Alberto Matteelli;Ibrahim Abubakar;Mohamed Abdel Aziz.
European Respiratory Journal (2015)
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
I. Solovic;M. Sester;J. J. Gomez-Reino;H. L. Rieder.
European Respiratory Journal (2010)
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
Dennis Falzon;Neel Gandhi;Giovanni B. Migliori;Giovanni Sotgiu.
European Respiratory Journal (2013)
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
Giovanni Sotgiu;Rosella Centis;Lia D'Ambrosio;Jan-William C. Alffenaar.
European Respiratory Journal (2012)
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
David J. Lederer;Scott C. Bell;Richard D. Branson;James D. Chalmers.
Annals of the American Thoracic Society (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: